Country:
Years:
Category:

Redge, Inc.

Redge, Inc. aims to provide sustainable and safe medical care to all over the world with clinical engineer technology. Medical devices are essential equipment for treating the patient in a hospital. However, the medical device failures are frequently happened in developing countries, resulting medical accidents and threatened patient’s lives. It is cause of lack of maintenance and education of medical devices in local area. In Japan, clinical engineer, national license is dealing with medical device to maintain high quality medicine. Therefore, Redge, Inc. provides “CeTrax”, packaging system including medical device management and education based on Japanese clinical engineer knowledge and experience. For management part, we provide a simple system that combines cloud database computing and AI image recognition. It leads to forecast medical device failure and balance supply & demand consumable parts based on prediction the working rate of medical device. For education part, combination of hands-on training and video contents will expand local medical provider resources. CeTrax will improve the quality and safety of medical devices in developing countries.

企業詳細はこちら→

RealBone Technology Co., Ltd.

Mesh Technology Taiwan provides Video as a Service and Infrastructure as a Service for private/public 5G networks. We combined 5G FWA and MEC to enable 5G applications on edge. Our 5G Distributed Edge Network supports trillions of connections from Smart City, Smart devices, and Smart Applications to Autonomous vehicles.

Our current clients cover Telehealth, Esports, Telcos (Smart Pole), etc.

Highlight 2021: Top 30 Taiwan Startups by BNext Media
Highlight 2022: Qualcomm 5G Innovative Taiwan Competition 1 of 10 finalists out of 200+ teams

RealBone® Technology Co. Ltd. has developed a new surface modification technology for calcium phosphate powder which obtained a Taiwan invention patent (Cert. No.: I427050) and Japan patent (JPN: 5280403).
The technology improves the physicochemical properties of the derived biomedical ceramics by increasing the linkages between the particles to allow crystal growth. Accordingly, we have developed an excellent product “REALBONE” resorbable calcium phosphate bone graft substitute (injectable).

Compared with other products, it not only has better operability, but also has good injectability and disintegration resistance. The initial setting time is 9 minutes, and compressive strength is 18-24MPa. It can be applied to various surgical operations that require strength, even under load-bearing conditions. This product has obtained the Class II medical device license from Food and Drug Administration of Taiwan in 2021. It has passed the trial procedure and has won the tender from Taipei Veterans General Hospital, and is waiting for tender at National Taiwan University Hospital. As a result, the product has flourished due to its wide range of applications to accelerate healing and thus improve the quality of life. Just like RealBone® Tech. slogans “REALBONE, Reborn all your bone & are those who make others’ Real Bone healthy”.

企業詳細はこちら→

Red Arrow Therapeutics Inc.

Red Arrow Therapeutics’ chemists shape the behavior of proteins by carefully designing polymer-protein conjugates with controlled architecture, composition, size and stimuli responsive chemistry. Our unique approach can then generate prodrug-like proteins with optimal pharmacokinetics, biodistribution and targeted activation at disease sites without compromising the biological action of the proteins. With our novel platform, a broad range of valuable functional attributes will become accessible for therapeutic innovation. As a 1st pipeline, we focused on immunotherapy, where only 20% patients respond to standard immunoncological options, such as immune checkpoint inhibitors (ICIs). Because the immunosuppressive environment of cold tumors is the major reason for immunotherapy failure, Red Arrow Therapeutics has developed protein prodrugs that safely boost antitumor immunity. To this end, we have identified the hit formulation capable of tumor eradication, even in malignancies that are resistant to ICIs, and we will optimize this formulation before large-scale manufacturing, pre-clinical trials and clinical trials. We are convinced that our proprietary platform will attract Japanese investors and pharmaceuticals to jointly develop products, and we aim to achieve IPO with our pipelines toward blockbuster drugs and alliances.

企業詳細はこちら→

Rumarocket Limited Incorporated

The pandemic has brought to the forefront a challenge that organizational leaders have dealt with for decades: how
do I keep my team productive and high performing while also ensuring that they’re mentally resilient and engaged
with their roles? For a long time, we thought that these were two different challenges, but the pandemic has led
many organizations to the realization that both challenges are the same problem: just two sides of the same coin.

“A Nudge: A prompt that changes behaviour”.

We are the first to exclusively use personalized Nudges powered by Behavioral Science + Machine Learning to
incentivize your talents to be more effective, motivated and engaged.

Our solution is tried and tested: we have successfully increased organizational sales in real estate by 600%, while
also increasing retention by 22%.

企業詳細はこちら→

Roceso Technologies Private Limited

Roceso Technologies is a world pioneer in soft robotic exoskeleton technologies. Its soft robotic solutions provide functional assistance to patients with limb motor function impairments during rehabilitation and daily living. The company’s flagship product, the EsoGLOVE, is one of the world lightest hand rehabilitation and exoskeleton devices offering top functionality and comfort. Since 2020, Roceso Technologies have expanded to three business units: Rehabilitation and Assistive Technologies, Venous Care and Contracture Management, Compression and Support.

企業詳細はこちら→

Rehab Happy Walk

世界中で800万人以上もの人々がパーキンソン病(PD)の症状であるすくみ足に悩まされており、歩行や難しくなっているだけでなく転倒のリスクや恐怖、鬱病のリスクも高くなっている。PDの患者数は60歳以降は1/100であり、社会の高齢化に伴い患者の数も増えている。Rehab Happy Walkはリハビリテーションを専門とし発明家でもあるピーラヤ博士と、社会の負担によってではなく自立して生活することでPD患者の生活の質を高めることを目指すチームによって設立された。
弊社のソリューションは臨床研究における患者や介護者のフィードバックに基づいて開発し検証した。本製品は特許申請中であり2019年には立ち上げられるとともに改善を続け、2020年までには第2バージョンを発表する予定である。弊社の市場計画ではまずマヒドル大学病院2棟、同地区にある病院6棟、およびタイ医療学会とのコラボレーションを通じてタイに集中する一方で、タイと同様に日本も完全な高齢化社会へ移行しつつあることを踏まえ、国際的に拡大するためにも日本との提携を目指す。PD患者は2020年までに150,000人にまで上る見込みである。弊社の2020年度の収益は$ 140万であり2023年には$1000万まで上昇する一方で、NPVは割引率40%として$54万となりIRRは80%である。
弊社では我々のビジョンに参加し共に前進できる投資家や提携企業を探している。

企業詳細はこちら→

Rayark Inc.

♦ 2011年9月 Rayark Inc.を設立。
♦ 2012年第1四半期 iOSとAndroid対応の音楽リズムゲーム「Cytus」をリリースし、高い評価を受ける。♦ 2012年第4四半期 iOSとAndroid対応のキャラクターベースカジュアルゲーム「Mandora」をリリース。3か月で400万ダウンロードを達成。♦ 2013年第2、第3四半期 モバイルプラットフォーム対応の音楽リズムゲーム新作2本をリリース予定。♦ 2013年第4四半期 次世代3Dアクションゲームをリリース予定。

各種プラットフォームに対応する高品質ゲームの創作にひたむきな情熱を傾けるゲーム開発者集団です。

コンテンツプロバイダーとして、オンラインとオフラインのアプリケーションの統合も模索しています。以下のようなイベントを開催しています。

♦ Cytusライブコンサート2012@台北
♦ Cytusミュージカル2013@ソウル
♦ Mandoraコレクターズ版の先行予約
♦ Rayarkアーティストコラボレーション2013

企業詳細はこちら→

RAD Green Solutions Inc.

世界人口の増加に伴い、ゴミの量が増加しています。人類はデジタル・携帯技術で大きな飛躍を遂げましたが、この技術を廃棄物管理に応用することはできません。

廃棄物管理方法における真の課題は持続性です。その方法は経済的に実現可能か? その方法を確立し、運営・保守管理を維持して行くことは経済的に可能か? また、地球温暖化に対する意識が高まりつつある今、我々は自らにこう問いかける必要があります――これは環境に優しい方法か?

RAD Green Solutionsはフィリピンのダバオ市を拠点とするクリーンテクノロジー企業として、上述の問題に取り組んでいます。弊社は、水を利用して、少量の燃料でより多くの熱を生み出す技術である「HYDROBURN」を開発しました。

同技術の用途としては、多くの可能性があります。その中で弊社は先ず、生体医学廃棄物に焦点を合わせました。最終的には、現在は世界各地のゴミ捨て場や埋立地で腐敗している都市廃棄物を、最も経済的な方法でエネルギーに転換する技術を開発することを目指しています。

企業詳細はこちら→